COI | conflict of interest |
COVID-19 | coronavirus disease 2019 |
DSS | data sharing statement |
FLV | fluvoxamine |
ITT | intention-to-treat |
IVM | ivermectin |
OR | odds ratio |
OTC | over-the-counter |
PP | per-protocol |
RCT | randomized clinical trial |
RR | relative risk |
SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
SP | spike protein |
SpO2 | peripheral oxygen saturation |